Treatment with Idelalisib in Patients with Relapsed or Refractory Follicular Lymphoma: The Observational Italian Multicenter FolIdela Study.
Casadei B, Argnani L, Broccoli A, Patti C, Stefani PM, Cuneo A, Margiotta Casaluci G, Visco C, Gini G, Pane F, D'Alò F, Luzi D, Cantonetti M, Pozzi S, Musuraca G, Rosignoli C, Arcari A, Kovalchuk S, Tani M, Tisi MC, Petrini M, Stefoni V, Zinzani PL.
Casadei B, et al. Among authors: musuraca g.
Cancers (Basel). 2022 Jan 27;14(3):654. doi: 10.3390/cancers14030654.
Cancers (Basel). 2022.
PMID: 35158922
Free PMC article.